$40.55

-0.76 (-1.84%)

5/9/2008 4:00 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AZN

Add Stock to Watchlist

What the Community Thinks

Total Players

263 Outperforms

23 Underperforms

All-Stars

85 Outperforms

7 Underperforms

Wall Street

7 Outperforms

1 Underperforms

Players bullish on AZN are also bullish on:

Players bearish on AZN are also bearish on:

Ticker Tags

Drug Manufacturers - Major (27), Major 2005 Lawsuit (8), Dividend (179), Mega Cap (146), Multinational Company (16), Big Pharma (12), United Kingdom (47), Major 2006 Lawsuit (3)
Suggest a tag

AstraZeneca plc (ADR) At A Glance

Current Price:	$40.55
Last Trade Time:	5/9/2008 4:00 PM
Open:	$0.00
Previous Close:	$41.31
Daily Range:	$40.28 - $40.83
52-Week Range:	$35.03 - $56.60
Volume:	1,060,106
Market Cap:	$60.19B
P/E Ratio:	11.05
Compare Our Special Broker Offers!

Stock Trends

AZN VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for AZN

Flu vaccine makers to set new doses record for next season
5/9/2008 1:57:00 PM - AP
Pozen projects full-year revenue above Wall Street estimates
5/8/2008 10:41:00 AM - AP
Pozen 1Q loss more than triples on higher operating expenses
5/8/2008 10:25:00 AM - AP
OSI shares rise after posting 1Q profit on cancer drug sales
5/7/2008 4:56:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

1 AstraZeneca plc (ADR) (AZN)

Avatar SESAMEnow (96.40) Submitted: 10/06/07 2:38 PM

Growth is the new name of the game. Drugs are the old name of the game. AZN is both

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1 AstraZeneca plc (ADR) (AZN)

Avatar KingPortu (75.49) Submitted: 10/29/07 2:34 PM

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Replies: 0 | Reply | Permalink

CAPS Players

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 48 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (AZN) AnomaLee (99.43) Submitted: 5/09/08 8:14 AM : Start Price: $41.11 AZN Score: 0.79 How much lower will this go? How much more disappointment will come? Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) deuspecuniae (27.97) Submitted: 5/01/08 12:11 PM : Start Price: $41.47 AZN Score: -1.71 The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) delocin (46.37) Submitted: 4/27/08 4:49 PM : Start Price: $42.39 AZN Score: -3.68 Two words: baby boomers. As boomers age, the drugs made by AstraZeneca will become more necessary. I expect this stock to double in the next 7-10 years. Of course, as new drugs come out and go through their trials with the FDA, or lose their patent protection, the stock will bounce around, generally going higher. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) psi21286 (77.82) Submitted: 4/25/08 3:45 PM : Start Price: $41.92 AZN Score: -2.82 Pharmaceuticals can be risky stocks, but the payoff can be pretty handsome. Go with what you know and make sure you have your information from a reliable source. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AZN) icanpickm (98.71) Submitted: 4/22/08 2:40 AM : Start Price: $40.63 AZN Score: -1.24 This seems like a no brainer, Crestor lowers the inflammation that causes heart attacks, even with patients with normal cholesterol. They halted their study early because the evidence was so strong. I am on it for cholesterol, but what a nice extra beny. The PE is 9 and the dividend is about 4.5%. I know big pharma is having their problems, but that has to be priced in. Long! Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 48 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 8 of 8

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Player Name	Player Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackJPMorgan	90.29	04/18/08		NS	$41.63	-2.59%	+0.28%	+2.88
	TrackCitigroup	86.06	04/02/08		NS	$40.46	+0.22%	+1.64%	-1.42
	TrackJimCramer	81.10	04/01/08		3W	$40.60	-0.12%	+1.68%	-1.80
	TrackHAndW	< 20	12/31/07		NS	$41.37	-1.97%	-5.00%	+3.03
	TrackBrandes	< 20	09/30/07		NS	$48.37	-16.17%	-8.97%	-7.20
	TrackEdwardOwens	73.59	09/30/07		NS	$48.37	-16.17%	-8.97%	-7.20
	TrackDeutscheSec	89.42	07/02/07		NS	$51.55	-21.34%	-7.93%	-13.41
	TrackBearStearns	93.79	01/12/07		NS	$52.65	-22.98%	-2.27%	-20.71

Results 1 - 8 of 8

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.